XGN
Exagen
$6.97
−$0.34 (−4.65%)Sep 10, 2026
Key metrics
The numbers that frame XGN today
- Market cap
- $168.85M
- P/E (TTM)
- -8.9
- EV / FCF
- -22.7
- Gross margin
- 58.6%
- EV / Sales
- 2.4
- ROIC
- -32.7%
- Div yield
- 0%
- Debt / equity
- 2.3
- 52wk Low
- $2.60
- 52wk High
- $12.23
Growth
Revenue and earnings trend for XGN
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about XGN
Is Exagen a good buy?
Yes. Exagen has mixed quality and excellent momentum. Taken together, the setup leans positive. Growth looks strong, which supports the long-term business case. We think Exagen is selling at a high price, which cuts against the buy case.
What is the market capitalization of XGN?
Exagen's market capitalization is $168.85M.
What is the P/E ratio for XGN stock?
Exagen's current P/E ratio is -8.9.
What is the 52-week high for XGN stock?
The 52-week high for Exagen is $12.23. The current close of $6.97 is 43% below that high.
What is the 52-week low for XGN stock?
The 52-week low for Exagen is $2.60. The current close of $6.97 is 168.1% above that low.
Does XGN stock pay dividends?
Exagen does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for XGN?
Exagen's Debt / Equity ratio is 2.26.